164 related articles for article (PubMed ID: 21448785)
1. Extracellular matrix metalloproteinase inducer is a negative prognostic factor of pediatric medulloblastoma.
Chu T; Chen X; Yu J; Xiao J; Fu Z
Pathol Oncol Res; 2011 Sep; 17(3):705-11. PubMed ID: 21448785
[TBL] [Abstract][Full Text] [Related]
2. A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma.
Zhao X; Song T; He Z; Tang L; Zhu Y
Med Oncol; 2010 Sep; 27(3):985-91. PubMed ID: 19806481
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma.
Chen T; Zhu J
Med Oncol; 2010 Dec; 27(4):1185-91. PubMed ID: 19921476
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix metalloproteinase inducer: a novel poor prognostic marker for human seminomas.
Bi XC; Liu JM; He HC; Ye YK; Han ZD; Dai QS; Liang YX; Cai C; Chen JH; Chen XB; Qin GQ; Zeng GH; Zhong WD
Clin Transl Oncol; 2012 Mar; 14(3):190-6. PubMed ID: 22374422
[TBL] [Abstract][Full Text] [Related]
5. Cellular localization of EMMPRIN predicts prognosis of patients with operable lung adenocarcinoma independent from MMP-2 and MMP-9.
Sienel W; Polzer B; Elshawi K; Lindner M; Morresi-Hauf A; Vay C; Eder F; Passlick B; Klein CA
Mod Pathol; 2008 Sep; 21(9):1130-8. PubMed ID: 18567995
[TBL] [Abstract][Full Text] [Related]
6. DJ-1 is activated in medulloblastoma and is associated with cell proliferation and differentiation.
Lin JP; Pan BC; Li B; Li Y; Tian XY; Li Z
World J Surg Oncol; 2014 Dec; 12():373. PubMed ID: 25475127
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications and prognostic value of EMMPRIN/CD147 and MMP2 expression in pediatric gliomas.
Gu J; Zhang C; Chen R; Pan J; Wang Y; Ming M; Gui W; Wang D
Eur J Pediatr; 2009 Jun; 168(6):705-10. PubMed ID: 18795327
[TBL] [Abstract][Full Text] [Related]
8. Highly expressed tumoral emmprin and stromal CD73 predict a poor prognosis for external auditory canal carcinoma.
Miyazaki M; Aoki M; Okado Y; Koga K; Hamasaki M; Nakagawa T; Sakata T; Nabeshima K
Cancer Sci; 2020 Aug; 111(8):3045-3056. PubMed ID: 32473077
[TBL] [Abstract][Full Text] [Related]
9. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma.
Davidson B; Goldberg I; Berner A; Kristensen GB; Reich R
Clin Exp Metastasis; 2003; 20(2):161-9. PubMed ID: 12705637
[TBL] [Abstract][Full Text] [Related]
10. EMMPRIN expression as a prognostic factor in radiotherapy of cervical cancer.
Ju XZ; Yang JM; Zhou XY; Li ZT; Wu XH
Clin Cancer Res; 2008 Jan; 14(2):494-501. PubMed ID: 18223224
[TBL] [Abstract][Full Text] [Related]
11. Expression of matrix metalloproteinase 2 and extracellular matrix metalloproteinase inducer are unfavorable postoperative prognostic factors in intrahepatic cholangiocarcinoma.
Zhang C; Tu Z; Du S; Wang Y; Wang Q
Pathol Oncol Res; 2010 Mar; 16(1):47-53. PubMed ID: 19629755
[TBL] [Abstract][Full Text] [Related]
12. Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer.
Dalberg K; Eriksson E; Enberg U; Kjellman M; Bäckdahl M
World J Surg; 2000 Mar; 24(3):334-40. PubMed ID: 10658069
[TBL] [Abstract][Full Text] [Related]
13. EMMPRIN co-expressed with matrix metalloproteinases predicts poor prognosis in patients with osteosarcoma.
Futamura N; Nishida Y; Urakawa H; Kozawa E; Ikuta K; Hamada S; Ishiguro N
Tumour Biol; 2014 Jun; 35(6):5159-65. PubMed ID: 24481662
[TBL] [Abstract][Full Text] [Related]
14. Expression patterns of emmprin and monocarboxylate transporter-1 in ovarian epithelial tumors.
Fukuoka M; Hamasaki M; Koga K; Hayashi H; Aoki M; Kawarabayashi T; Miyamoto S; Nabeshima K
Virchows Arch; 2012 Oct; 461(4):457-66. PubMed ID: 22926487
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of extracellular matrix metalloproteinase inducer in prostate cancer is associated with high risk of prostate-specific antigen relapse after radical prostatectomy.
Bi XC; Liu JM; Zheng XG; Xian ZY; Feng ZW; Lou YX; Zhong WD; Wu CL
Clin Invest Med; 2011 Dec; 34(6):E358. PubMed ID: 22129926
[TBL] [Abstract][Full Text] [Related]
16. EMMPRIN expression is associated with metastatic progression in osteosarcoma.
Kim HS; Kim HJ; Lee MR; Han I
BMC Cancer; 2021 Sep; 21(1):1059. PubMed ID: 34565336
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic implications of CD1d expression and tumor-infiltrating macrophages in pediatric medulloblastomas.
Teo WY; Elghetany MT; Shen J; Man TK; Li X; Chintagumpala M; Su JM; Dauser R; Whitehead W; Adesina AM; Lau CC
J Neurooncol; 2014 Nov; 120(2):293-301. PubMed ID: 25115738
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis.
Zhao F; Zhang J; Li P; Zhou Q; Zhang S; Zhao C; Wang B; Yang Z; Li C; Liu P
J Neurooncol; 2018 Sep; 139(2):333-340. PubMed ID: 29687281
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin receptors and heparanase: a functional axis in human medulloblastoma invasion.
Marchetti D; Mrak RE; Paulsen DD; Sinnappah-Kang ND
J Exp Clin Cancer Res; 2007 Mar; 26(1):5-23. PubMed ID: 17550129
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and clinical implication of a disintegrin and metalloprotease 8 expression in pediatric medulloblastoma.
Zhang R; Yuan Y; Zuo J; Liu W
J Neurol Sci; 2012 Dec; 323(1-2):46-51. PubMed ID: 22959284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
